Is ICLR stock a Buy, Sell, or Hold?

Based on our analysis, ICLR is currently a HOLD with moderate confidence. 📊 HOLD: ICLR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of ICLR stock?

Our analysis estimates the fair value range for ICLR to be between $105.50 and $116.57. The current price is $124.49.

What is the analyst price target for ICLR?

The average Wall Street analyst price target for ICLR is $135.07. This implies a potential upside of 8.5% from current levels.

ICLR Stock Analysis: Buy, Sell, or Hold?

ICLR - Icon Plc

Services-Commercial Physical & Biological Research

$124.49

-0.51 (-0.41%) ▼

5d: +10.31%

30d: +16.67%

90d: -17.33%

HOLD

MODERATE Confidence

Protect Your ICLR Gains

Analysis Updated: May 8, 2026 12:00 AM ET

Earnings: May 13, 2026 2d

Smart Money Accumulation

ICLR is down 11.0% this week, but smart money is accumulating calls. Top strike: $130 2026-06-18 with 209 OI. Call ratio: 71% View Scanner →

Strength: 7.6/10

Get Alerted When ICLR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: ICLR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -9.5%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$107.24

Based on -2.7% avg growth

INTRINSIC VALUE TODAY

$66.59

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ICLR is currently trading at $124.49, which is considered extended relative to its 30-day fair value range of $105.50 to $116.57. The stock's valuation (Forward PE: 10.7) is in line with its historical norms (10.7). At these levels, the market is pricing in 0.1% annual earnings growth.

Technical Outlook: Technically, ICLR is in a strong downtrend. Immediate support is located at $99.06, while resistance sits at $129.73.

Market Sentiment: ICLR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $105.50 - $116.57

Company Quality Score 63/100 (BUY)

Volume Confirmation HIGH

Confidence Score 55.7%

Protect Your Profits

Holding ICLR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range (+6.8% above its trading range)
BULLISH: Strong technical setup (75/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($135.07)
BULLISH: Expecting earnings turnaround to 0.1% growth with 0.6% revenue growth

Trading Range Analysis

30-Day Trading Range $105.50 - $116.57

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $99.06

Resistance Level $129.73

Current Trend Strong Downtrend

Technical data as of May 8, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.74

Wall Street Target $135.07 (+8.5%)

Revenue Growth (YoY) 0.6%

Earnings Growth (YoY) -98.7%

Profit Margin 7.4%

Valuation Premium vs History +0.1% premium

PE vs Historical 10.7 vs 10.7 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +0.1% (market-implied from PE analysis)

1-Year Target $124.61 (+0%)

2-Year Target $124.74 (+0%)

3-Year Target $124.86 (+0%)

3-Yr Target (if PE normalizes) (PE: 11→11) PE COMPRESSION $124.40 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 21.9, Growth: -9.5%) $188.33 (+51%)

Base: (SPY PE: 10.7, Growth: -9.5%) $92.19 (-26%)

Bear: (PE: 9.1, Growth: -9.5%) $78.36 (-37%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (11x PE) as earnings recover.

Trailing PE: 16.85 | Current EPS (TTM): $7.42

Bull Case $214.80 (+73%)

Analyst growth 56.2%, PE expands to 18.5

Base Case $195.28 (+57%)

Market implied 56.2%, PE stable at 16.9

Bear Case $85.00 (-32%)

Severe decline -20.0%, PE contracts to 14.3

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 10, 2026 3:38 PM ET
Data refreshes hourly during market hours. Next update: 4:38 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ICLR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ICLR.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
TMO Thermo Fisher Scientific…	STRONG BUY 31 analysts	$620	55 HOLD
EXAS EXACT Sciences Corporati…	STRONG BUY 26 analysts	$106	65 BUY
DHR Danaher Corporation	STRONG BUY 26 analysts	$250	55 HOLD
GH Guardant Health Inc	STRONG BUY 24 analysts	$130	62 BUY
NTRA Natera Inc	STRONG BUY 21 analysts	$261	61 BUY

TMO Thermo Fisher Sci…

55 HOLD

EXAS EXACT Sciences Co…

65 BUY

DHR Danaher Corporati…

55 HOLD

GH Guardant Health I…

62 BUY

NTRA Natera Inc

61 BUY

Advanced ICLR Option Strategies

Professional options setups generated by AI based on today's ICLR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ICLR

ICLR Technical Chart ICLR Price Prediction ICLR Earnings Date ICLR Investment Advisor ICLR Fair Price Analyzer ICLR Options Advisor ICLR Options Chain ICLR Options Analysis ICLR Competitors

Compare ICLR with Peers

ICLR vs CRL
Which one to buy?

ICLR vs IQV
Which one to buy?

ICLR vs MEDP
Which one to buy?

ICLR vs BRKR
Which one to buy?

ICLR vs WST
Which one to buy?

ABSI vs ICLR

MEDP vs ICLR
Winner: Tie

BRKR vs ICLR

IQV vs ICLR

WAT vs ICLR

MTD vs ICLR
Winner: MTD

DGX vs ICLR

CRL vs ICLR
Winner: ICLR

EXAS vs ICLR

ILMN vs ICLR
Winner: ILMN

Create New Comparison View All Competitors

Tradestie